rhubarb
Botanicalexperimental
Rhubarb is the fleshy, edible stalks (petioles) of species and hybrids of Rheum in the family Polygonaceae, which are cooked and used for food. The plant is a herbaceous perennial that grows from short, thick rhizomes. Historically, different plants have been called "rhubarb" in English. The large, triangular leaves contain high levels of oxalic acid and anthrone glycosides, making them inedible. The small flowers are grouped in large compound leafy greenish-white to rose-red inflorescences. — Wikipedia
Clinical trial activity
6 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2007 (NCT00569088)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaRhubarb ↗
- NCATSG280W4MW6E ↗
Also known as
- rhubarb
- rhubarb
- rhubarb
- rhubarb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04990336 | N/A | Sep 1, 2021 | Sun Yat-Sen University |
| NCT05541991 | N/A | Feb 10, 2017 | CEN Biotech |
| NCT02545777 | Phase 2 | May 1, 2014 | Peking University |
| NCT00789269 | Phase 2 | Jan 1, 2009 | Fudan University |
| NCT00815737 | Phase 2/Phase 3 (Phase 3) | Jan 1, 2009 | Fudan University |
| NCT00569088 | Phase 2 | Nov 1, 2007 | Nanjing University of Traditional Chinese Medicine |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fudan University | Academic/Hospital | 2 | 2 | 2 | 2009 |
| CEN Biotech | For profit | 1 | 0 | 1 | 2017 |
| Nanjing University of Traditional Chinese Medicine | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 1 | 1 | 2021 |
5 organizations
Page 1 / 1